ARQT

NASDAQStock

Arcutis Biotherapeutics, Inc.

$22.70-0.20 (-0.89%)

52-Week Range

$12.59
$31.20

Key Stats

Market Cap

2.8B

P/E Ratio

Dividend Yield

Beta

1.74

Volume

597.4K

Avg Volume

1.6M

Performance

1M

-14.23%

3M

-20.86%

6M

+35.32%

YTD

-21.00%

1Y

+56.70%

3Y

+106.21%

5Y

-29.59%

Price Chart

ETF Exposure

ARQT is held by 107 ETFs

ETFFund NameWeight
SXRG.DEiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.06%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.06%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.05%
URTYProShares - UltraPro Russell20000.05%
ISCBiShares Morningstar Small-Cap ETF0.04%
JKJiShares Morningstar Small-Cap ETF0.04%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.04%
VHTVanguard Health Care ETF0.04%
CBUG.DEiShares $ Treasury Bond 3-7yr UCITS ETF0.04%
VXFVanguard Extended Market ETF0.04%
IUSN.DEiShares MSCI World Small Cap UCITS ETF0.03%
WDSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.03%
WOSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.03%
WSML.LiShares MSCI World Small Cap UCITS ETF0.03%
ZPRS.DEState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.03%
WSMLiShares MSCI World Small-Cap ETF0.03%
SMMDiShares Russell 2500 ETF0.02%
FSMOFidelity Small-Mid Cap Opportunities ETF0.01%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.01%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
IMID.LState Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
SPYI.DEState Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
PreviousPage 2 of 3Next

About ARQT ETF Exposure

Arcutis Biotherapeutics, Inc. (ARQT) is held by 107 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.8B, ARQT is a widely held institutional stock. The stock currently trades at $22.70. Investors can gain exposure to ARQT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARQT, sorted by portfolio weight.